Back to search

Article

SERPINB13 is a prognostic biomarker for LUSC associated with an immune-inflamed tumor phenotype and modulated by immune cells

2026-07-16

Abstract excerpt

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer accounting for most cancer-related deaths worldwide. Despite substantial recent advances in targeted therapies and immunotherapy, the prognosis for advanced-stage disease remains comparably poor, which is why the identification of novel molecular biomarkers as well as therapeutic targets influencing tumor development, progression, and metast...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
00fd6d48-0f3b-53ac-8bcb-f7043bee5388
DOI
10.64898/2026.07.11.737907
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SERPINB13 is a prognostic biomarker for LUSC associated with an immune-inflamed tumor phenotype and modulated by immune cellsDOI 10.64898/2026.07.11.737907
SCCA1/SERPINB3 promotes suppressive immune environment via STAT-dependent chemokine production, blunting the therapy-induced T cell responsesSemantic proximity
Development and validation of an individualized immune prognostic model in stage I-III lung squamous cell carcinoma.Semantic proximity
Tumor-derived KLK8 predicts inferior survival and promotes an immune-suppressive tumor microenvironment in lung squamous cell carcinomaSemantic proximity
Single cell profiling of bronchoalveolar immune cells in checkpoint inhibitor-related pneumonitisSemantic proximity
Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinomaSemantic proximity
Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden.Semantic proximity
Integrative Analysis of the Expression of SIGLEC Family Members in Lung Adenocarcinoma via Data MiningSemantic proximity
Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burdenSemantic proximity
SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial‐mesenchymal transition ( EMT) in lung adenocarcinomaSemantic proximity
CLEC3B as a Prognostic and Immunological Biomarker in Pan-Cancer: Multi-Omics Profiling and Validation in Pancreatic Cancer and ExosomesSemantic proximity
Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancerSemantic proximity
Comprehensive Analysis of PSME2 and Its Significant Role in Non- small cell lung cancerSemantic proximity
Select a neighboring publication to make it the new centre.